NIH Guide: Weekly Index for November 29, 2024

Funding Opportunities

• Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
  (PA-25-163)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
• Alcohol Health Services Research (R01 Clinical Trial Optional)
  (PA-25-245)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
  (PAR-25-134)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
  (PAR-25-158)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
• Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
  (PAR-25-159)
  National Institute on Alcohol Abuse and Alcoholism
  Office of Disease Prevention
  Application Receipt Date(s): Multiple dates, see announcement.
• Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
  (PAR-25-177)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
  (PAR-25-178)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
  (PAR-25-179)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
  (PAR-25-180)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
  (PAR-25-181)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
  (PAR-25-182)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
  (PAR-25-183)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
  (PAR-25-184)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Alcohol Health Services Research (R34 Clinical Trial Optional)
  (PAR-25-192)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
• Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
  (PAR-25-193)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
• Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed)
  (PAR-25-214)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
• NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
  (PAR-25-238)
  National Library of Medicine
  Application Receipt Date(s): Multiple dates, see announcement.
• New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
  (PAR-25-272)
  National Institute on Aging
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
  (PAR-25-279)
  National Institute on Aging
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
  (PAR-25-285)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
  (PAR-25-288)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
  (PAR-25-289)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
  (PAR-25-292)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• HIV Prevention and Alcohol (R34 Clinical Trials Optional)
  (PAS-25-161)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Not Applicable
• HIV Prevention and Alcohol (R01 Clinical Trials Optional)
  (PAS-25-208)
  National Institute on Alcohol Abuse and Alcoholism
  Office of Disease Prevention
  Application Receipt Date(s): Not Applicable